Sarepta Therapeutics, Inc.
COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
Last updated:
Abstract:
Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
Status:
Application
Type:
Utility
Filling date:
21 Oct 2021
Issue date:
3 Feb 2022